(Q51948005)

18 April 2018

title

Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. (English)

1 reference

18 April 2018

1 reference

1

1 reference

18 April 2018

Jason Brandt

9

1 reference

18 April 2018

Yaakov Stern

10

1 reference

18 April 2018

Steven Albert

Steven M Albert

4

0 references

Marilyn S. Albert

8

Marilyn Albert

1 reference

18 April 2018

6

Karen Marder

1 reference

18 April 2018

Ming-Xin Tang

2

Ming-Xin Tang

1 reference

18 April 2018

Karen Bell

7

Karen Bell

1 reference

18 April 2018

author name string

D P Devanand

3

1 reference

18 April 2018

Domonick J Wegesin

5

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

18 April 2018

Journal of the American Geriatrics Society

published in

1 reference

18 April 2018

volume

51

1 reference

18 April 2018

issue

7

1 reference

18 April 2018

page(s)

953-960

1 reference

18 April 2018

Delusions in Alzheimer's disease: a review.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

The course of psychopathologic features in mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Relation of cognitive status and abnormal behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Clinical variables associated with psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Wandering: a significant problem among community-residing individuals with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Behavioral disturbance in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Risk factor and behavioral differences between vascular and Alzheimer's dementias: the pathway to end-stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Physical aggression in dementia patients and its relationship to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Psychosis and physical aggression in probable Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Prevalence and correlates of aggressive behavior in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

Assessing patient dependence in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

The Columbia University Scale for Psychopathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

A comparison of clinical methods for assessing dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51308.X

10.1046/J.1365-2389.2003.51308.X

21 January 2018

Identifiers

DOI

1 reference

18 April 2018

1 reference

18 April 2018